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The case for sex- and gender-sensitivity in (bio)medicine and health
is becoming more and more compelling. Funding agencies in Europe [1],
Canada [2] and the USA [3] are requesting that sex and/or gender be con-
sidered in grant applications. Scientific journals [4,5] increasingly
embrace the need to publish sex-disaggregated data. Even scientific soci-
eties are supporting the subject [6]. Yet, our everyday practice is still very
far from being sex-sensitive, let alone gender-sensitive.
Sex- and gender-sensitive medicine (SGSM) focuses on the role that
biological differences (sex) and socio-cultural power structures (gender)
play in healthcare. How both sex and gender affect health behavior, the
development of diseases, their diagnosis, management and long-term
effects. Furthermore, SGSM can focus on the structure of the healthcare
system, on how traded traditions impact the make-up of the workforce
and its opportunities. This, in turn, reflects on the care that is being pro-
vided and the research that is being conducted.
SGSM has emerged over the last twenty to thirty years. Initially its
focus was on differences in incidence of mortality between females
and males [7], or, more precisely, on filling the gap of knowledge
about female symptoms and needs in a medical world focused on
male standards [8]. Next came sex-specific basic research with the
objective to identify the causes of sex differences in disease develop-
ment and progression. And while scholars in the social sciences
already talked about gender in health in the 1970s, medicine discov-
ered the concept much later. Unfortunately, translating a concept
from the social sciences into the medical field is not easy. The first
attempts at introducing gender in (bio)medicine frequently simply
meant the interchangeable use of the terms sex and gender.
Although the knowledge and methods are increasing [9], we are still
lacking sound and systematic instruments for the analysis of gender in
medicine. It does not help that gender can be broken down into numer-
ous sub-categories; such as gender identity, gender norms, gender rela-
tionships just to name a few. Developing these methods often means
walking a fine line between perpetuating stereotypes and distilling
health-relevant information. Which leads to the question: which
aspects of gender do we need to know to improve people’s health?
The answer to this question takes us back to what we consider
health. Is it solely the absence of sickness, the development of
increasingly individualized diagnostic tests that will guide our choice
of targeted drug therapies? Or do we choose the WHO’s definition of
“a state of complete physical, mental and social well-being” [10] plac-
ing an emphasis on the structural, social and global drivers of peo-
ple’s lives?
In sex- and gender-sensitive medicine these questions could be
provocatively translated into: How do we transcend from research
focused primarily on privileged realities to include topics and schol-
ars that can address the impact of gender on health in all its breadth?
The present collection of articles in EClinicalMedicine is a very
good representation of this complex reality. Gender affects access to
healthcare, social dynamics, health behaviors, and it shapes the work
environment we find ourselves in. Gender impacts our chances of
survival, in single families according to birth order and gender repre-
sentation (Raj et al., in this collection) or at the population level,
where gender equity appears to reduce mortality not just in women
but also in men (Gadoth et al., in this collection). To change unequal
practices, which generally disadvantage women, approaches should
be participatory and include knowledge rooted in communities
(Hazra et al., in this collection). Health promotion interventions
should target structural barriers to transform gender stereotypes
rather than focusing solely on individual behavior (Bhan et al., in this
collection). Gender congruence among users and healthcare pro-
viders can influence the uptake of maternal health services (Bhan et
al., in this collection) and gender discrimination can significantly
impact mental health (Stepanikova et al., in this collection). Last, gen-
der does not just affect the populations and patients we care for, it
also impacts the careers of women researchers in the academic world
(Raj et al., in this collection).
Gender is not a unidimensional variable; it is complex, inter-
twined with our lived realities and affects all aspects of our health.
Including gender into our work is essential to achieving that “state of
complete physical, mental and social well-being” for all; it’s time to
make it a priority.
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